top border
top border
Featured Programs
Dr. Levy on Impact of Nivolumab, Pembrolizumab Approvals in NSCLC
Benjamin P. Levy, MD, assistant professor of Medicine, Hematology, and Medical Oncology at Mount Sinai Hospital, discusses how nivolumab (Opdivo) and pembrolizumab (Keytruda) have impacted the treatment landscape of non–small cell lung cancer (NSCLC). View Now

In this segment, Dean F. Bajorin, MD, and Evan Y. Yu, MD, discuss atezolizumab in muscle-invasive bladder cancer. View Now

 

Featured Video
Novel Combination Approaches for Metastatic Kidney Cancer
Brian Rini, MD, and David F. McDermott, MD, discuss novel combination approaches for patients with metastatic renal cell carcinoma. View now

Gina Columbus

Gina Columbus highlights the latest news in oncology in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x